Transaction in Own Shares

 
TIDMNVOB 
 
Company Announcement 
 
4 January 2010 
 
Status regarding Novo Nordisk's holding of its own shares (31 December 2009) 
 
In continuation of the company's announcement dated 6 August 2009 concerning a 
planned share repurchase programme, and pursuant to Section 204.25 of the New 
York Stock Exchange Listed Company Manual, this is to report that Novo Nordisk 
A/S (NYSE: NVO) and its wholly-owned affiliates on 31 December 2009 owned 
32,137,945 of its own B shares of DKK 1, corresponding to a total nominal value 
of DKK 32,137,945 or 5.18% of the total share capital. 
 
In the fourth quarter of 2009 a total of 4,534,767 B shares were repurchased, 
and 120,630 B shares were disposed of to employees in connection with employee 
incentive programmes. 
 
 
Novo Nordisk is a healthcare company and a world leader in diabetes care. In 
addition, Novo Nordisk has a leading position within areas such as haemostasis 
management, growth hormone therapy and hormone replacement therapy. Novo Nordisk 
manufactures and markets pharmaceutical products and services that make a 
significant difference to patients, the medical profession and society. With 
headquarters in Denmark, Novo Nordisk employs more than 29,000 employees in 81 
countries, and markets its products in 179 countries. Novo Nordisk?s B shares 
are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed 
on the New York Stock Exchange under the symbol ?NVO?. For more information, 
visitnovonordisk.com <http://www.novonordisk.com/>. 
 
  For further information please contact: 
 
 
 Media:                                  Investors: 
 
 
 Outside North America:                  Outside North America: 
 
 Elin K Hansen                           Mads Veggerby Lausten 
 
 Tel: [phone]                    Tel: [phone] 
 
 [e-mail]                     [e-mail] 
 <mailto:[e-mail]>            <mailto:[e-mail]> 
 
 
                                         Kasper Roseeuw Poulsen 
 
                                         Tel: [phone] 
 
                                         [e-mail] 
                                         <mailto:[e-mail]> 
 
 
 In North America:                       In North America: 
 
 Sean Clements                           Hans Rommer 
 
 Tel: [phone]                  Tel: [phone] 
 
 [e-mail]                    [e-mail] 
 <mailto:[e-mail]>           <mailto:[e-mail]> 
 
 
Company Announcement no 1 / 2010 
 
 
 
[HUG#1369894] 
 
 
 
 
 
    Company Announcement  no 1 2010: http://hugin.info/2013/R/1369894/335032.pdf